PeptiGrowth Inc.

PeptiGrowth develop novel Synthetic Peptide Growth Factors
Conventional growth factors and cytokines used in the manufacturing of regenerative medicine and cell therapy products face various quality challenges such as lot-to-lot variation, potential contamination with biological impurities, low stability, and high cost. PeptiGrowth has been working on the development of a series of synthetic peptides that can address these challenges while maintaining equivalent function to the conventional growth factors and cytokines in the market. Our peptides are completely chemically synthesized and animal component-free, enabling Xeno-free and chemically defined cell culture media.